IL-26 is associated with the activation of Th17 and CD4+ IL-22+ T-cells (42, 43); it also plays a role in inflammatory bowel disease, which may associate with the extra-pulmonary gastroenteritis manifestation during SMPP (44). Here, CD4 is linked to inflammatory bowel disease.